Edition:
United States

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

14.30EUR
12:35pm EDT
Change (% chg)

€0.03 (+0.21%)
Prev Close
€14.27
Open
€14.37
Day's High
€14.53
Day's Low
€14.30
Volume
7,884
Avg. Vol
41,141
52-wk High
€28.18
52-wk Low
€11.50

Latest Key Developments (Source: Significant Developments)

Erytech Pharma FY net loss widens to 22.0 mln euros
Thursday, 2 Mar 2017 12:37pm EST 

Erytech Pharma SA : FY no revenue versus no revenue year ago . FY net loss amounts to 22.0 million euros ($23.1 million) versus a loss of 15.0 million euros a year ago . FY operating loss is 22.5 million euros versus a loss of 15.6 million euros a year ago .Cash position at Dec 31 37.7 million euros.  Full Article

Erytech Pharma H1 net loss widens to 10.3 mln euros
Tuesday, 6 Sep 2016 01:00pm EDT 

Erytech Pharma SA : H1 no revenue versus no revenue year ago . H1 net loss 10.3 million euros ($11.58 million) versus loss of 6.5 million euros year ago .H1 operating loss 10.6 million euros versus loss of 6.9 million euros year ago.  Full Article

Erytech Pharma cash position of 40.6 million euros at end of Q1
Tuesday, 10 May 2016 12:30pm EDT 

Erytech Pharma SA :Solid cash position of 40.6 million euros at Q1 quarter-end.  Full Article

Erytech Pharma presents additional results from trial with GRASPA
Tuesday, 8 Dec 2015 02:00am EST 

Erytech Pharma SA:Announces that investigators presented additional results from the pivotal Phase 2/3 clinical trial with GRASPA.Says additional results add to the body of data supporting the potential benefit of GRASPA in combination with chemotherapy in the treatment of Acute Lymphoblastic Leukemia (ALL).  Full Article

Erytech Pharma raises about 25.4 mln euros in private placement
Monday, 7 Dec 2015 12:40pm EST 

Erytech Pharma SA:Erytech raises approximately 25.4 million euros in a private placement.  Full Article

Erytech Pharma raises about 25.4 mln euros in private placement
Thursday, 3 Dec 2015 02:31am EST 

Erytech Pharma SA:Raises about 25.4 mln euros within private placement with European and U.S. investors.Placement of 940,000 new shares with nominal value of 0.10 euro, at price of 27.00 euros, including share premium.Represents total of about 25.4 million euros or 14 pct of company's share capital.  Full Article

Erytech Pharma announces issuance of new United States patent
Wednesday, 23 Sep 2015 12:02pm EDT 

Erytech Pharma SA:Announces issuance of United States patent for Erythrocytes Containing Arginine Deiminase.  Full Article

Erytech Pharma submits EMA Marketing Authorization Application for GRASPA
Monday, 14 Sep 2015 12:33pm EDT 

Erytech Pharma SA:Submits EMA Marketing Authorization Application for GRASPA to treat acute lymphoblastic leukemia.  Full Article

Eric Soyer appointed as COO & CFO of Erytech Pharma
Tuesday, 1 Sep 2015 12:00pm EDT 

Erytech Pharma SA:Erytech appoints Eric Soyer as chief financial and chief operating officer.  Full Article

Erytech Pharma announces plans for initial public offering in United States
Tuesday, 28 Jul 2015 06:00am EDT 

Erytech Pharma SA:Announces plans to conduct registered initial public offering in the United States.  Full Article

More From Around the Web

BRIEF-Erytech to present preclinical results supporting immunotherapy potential of Erymmune platform at two upcoming medical meetings

* To present preclinical results supporting immunotherapy potential of Erymmune platform at two upcoming medical meetings Source text for Eikon: Further company coverage: (Gdynia Newsroom)